Biofarmex

Biofarmex is a Mexican pharmaceutical company specializing in the development, manufacturing, and commercialization of generic drugs. Founded in 1985 and headquartered in Tlalnepantla, the company operates a manufacturing facility that complies with Good Manufacturing Practices (GMP) to produce a variety of dosage forms, including oral solids and liquids. Its portfolio spans multiple therapeutic areas such as infectious diseases, gastroenterology, and pain management, featuring widely used molecules like amoxicillin, omeprazole, and diclofenac. Biofarmex plays a key role in the Mexican healthcare landscape by providing affordable, high-quality therapeutic alternatives to both institutional and private markets.